Operational Update and Accelerated Entitlement Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Operational Review & Management Reorganisation
- FebriDx Update - Brazil Market Authorisation & New Study
- FY2022 Half Year Update
- Lumos Diagnostics FY22 First Half Year Results
- Change To Lumos Board
Later from Lumos Diagnostics
- Target Market Determination
- Successful Completion of Institutional Entitlement Offer
- Lumos secures initial development services contract
- Lumos Diagnostics Appoints Doug Ward as CEO
- Security Class Suspension from Quotation LDXO
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics